PL2484661T3 - Pochodna 2,3-dihydro-1h-inden-2-ylomocznika i jej zastosowanie farmaceutyczne - Google Patents
Pochodna 2,3-dihydro-1h-inden-2-ylomocznika i jej zastosowanie farmaceutyczneInfo
- Publication number
- PL2484661T3 PL2484661T3 PL10820624T PL10820624T PL2484661T3 PL 2484661 T3 PL2484661 T3 PL 2484661T3 PL 10820624 T PL10820624 T PL 10820624T PL 10820624 T PL10820624 T PL 10820624T PL 2484661 T3 PL2484661 T3 PL 2484661T3
- Authority
- PL
- Poland
- Prior art keywords
- indene
- dihydro
- same
- pharmaceutical application
- ylurea derivative
- Prior art date
Links
- UBJNMSFVNGJGNO-UHFFFAOYSA-N 2,3-dihydro-1h-inden-2-ylurea Chemical class C1=CC=C2CC(NC(=O)N)CC2=C1 UBJNMSFVNGJGNO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009227411 | 2009-09-30 | ||
| JP2010083722 | 2010-03-31 | ||
| PCT/JP2010/067047 WO2011040509A1 (ja) | 2009-09-30 | 2010-09-30 | 2,3-ジヒドロ-1h-インデン-2-イルウレア誘導体及びその医薬用途 |
| EP10820624.4A EP2484661B1 (en) | 2009-09-30 | 2010-09-30 | 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2484661T3 true PL2484661T3 (pl) | 2017-10-31 |
Family
ID=43826321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10820624T PL2484661T3 (pl) | 2009-09-30 | 2010-09-30 | Pochodna 2,3-dihydro-1h-inden-2-ylomocznika i jej zastosowanie farmaceutyczne |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8653304B2 (pl) |
| EP (1) | EP2484661B1 (pl) |
| JP (1) | JP5573677B2 (pl) |
| KR (1) | KR101413533B1 (pl) |
| CN (1) | CN102574781B (pl) |
| AU (1) | AU2010301449B2 (pl) |
| CA (1) | CA2774040C (pl) |
| DK (1) | DK2484661T3 (pl) |
| ES (1) | ES2634470T3 (pl) |
| HU (1) | HUE032947T2 (pl) |
| PL (1) | PL2484661T3 (pl) |
| PT (1) | PT2484661T (pl) |
| WO (1) | WO2011040509A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017038870A1 (ja) * | 2015-08-31 | 2017-03-09 | 東レ株式会社 | 尿素誘導体及びその用途 |
| CA2991697A1 (en) | 2015-08-31 | 2017-03-09 | Toray Industries, Inc. | Urea derivative and use therefor |
| WO2017038871A1 (ja) | 2015-08-31 | 2017-03-09 | 東レ株式会社 | 尿素誘導体及びその用途 |
| TW201730189A (zh) | 2015-12-23 | 2017-09-01 | 吉斯藥品公司 | 激酶抑制劑 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU632809B2 (en) * | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
| ZA903906B (en) | 1989-05-25 | 1992-02-26 | Takeda Chemical Industries Ltd | Benzocycloalkane derivatives and production thereof |
| MX9300141A (es) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| US6093742A (en) * | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
| WO1999032463A1 (en) * | 1997-12-22 | 1999-07-01 | Bayer Corporation | INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| WO1999064400A1 (en) | 1998-06-12 | 1999-12-16 | Vertex Pharmaceuticals Incorporated | INHIBITORS OF p38 |
| UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| KR100523120B1 (ko) | 1999-10-21 | 2005-10-20 | 에프. 호프만-라 로슈 아게 | P38 단백질 키나제 저해제로서 헤테로알킬아미노-치환된이환 질소 헤테로환 |
| MXPA03009361A (es) * | 2001-04-13 | 2004-01-29 | Boehringer Ingelheim Pharma | Compuestos de urea utilies como agentes anti-inflamatorios. |
| CA2458611C (en) * | 2001-08-28 | 2012-05-29 | Leo Pharma A/S | Aminobenzophenones as interleukin 1-beta and tumour necrosis factor-alpha inhibitors |
| GB0124932D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| US7205318B2 (en) | 2003-03-18 | 2007-04-17 | Bristol-Myers Squibb Company | Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors |
| DE602004007382T2 (de) | 2003-05-20 | 2008-04-17 | Bayer Pharmaceuticals Corp., West Haven | Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten |
| JP2007145819A (ja) | 2005-10-28 | 2007-06-14 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US20070225339A1 (en) | 2006-03-07 | 2007-09-27 | Ramon Mohanlal | Compositions and methods for treating rheumatoid arthritis |
-
2010
- 2010-09-30 WO PCT/JP2010/067047 patent/WO2011040509A1/ja not_active Ceased
- 2010-09-30 JP JP2010540741A patent/JP5573677B2/ja not_active Expired - Fee Related
- 2010-09-30 CA CA2774040A patent/CA2774040C/en not_active Expired - Fee Related
- 2010-09-30 KR KR1020127008178A patent/KR101413533B1/ko not_active Expired - Fee Related
- 2010-09-30 US US13/497,819 patent/US8653304B2/en not_active Expired - Fee Related
- 2010-09-30 DK DK10820624.4T patent/DK2484661T3/en active
- 2010-09-30 AU AU2010301449A patent/AU2010301449B2/en not_active Ceased
- 2010-09-30 PL PL10820624T patent/PL2484661T3/pl unknown
- 2010-09-30 PT PT108206244T patent/PT2484661T/pt unknown
- 2010-09-30 ES ES10820624.4T patent/ES2634470T3/es active Active
- 2010-09-30 HU HUE10820624A patent/HUE032947T2/en unknown
- 2010-09-30 EP EP10820624.4A patent/EP2484661B1/en not_active Not-in-force
- 2010-09-30 CN CN201080043700.9A patent/CN102574781B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUE032947T2 (en) | 2017-11-28 |
| EP2484661A1 (en) | 2012-08-08 |
| AU2010301449B2 (en) | 2013-03-14 |
| US20120184735A1 (en) | 2012-07-19 |
| EP2484661B1 (en) | 2017-04-26 |
| PT2484661T (pt) | 2017-06-05 |
| CA2774040C (en) | 2014-09-09 |
| AU2010301449A1 (en) | 2012-03-08 |
| US8653304B2 (en) | 2014-02-18 |
| KR20120050504A (ko) | 2012-05-18 |
| JPWO2011040509A1 (ja) | 2013-02-28 |
| ES2634470T3 (es) | 2017-09-27 |
| JP5573677B2 (ja) | 2014-08-20 |
| EP2484661A4 (en) | 2013-02-27 |
| WO2011040509A1 (ja) | 2011-04-07 |
| CN102574781A (zh) | 2012-07-11 |
| DK2484661T3 (en) | 2017-06-06 |
| KR101413533B1 (ko) | 2014-07-01 |
| CN102574781B (zh) | 2014-02-19 |
| CA2774040A1 (en) | 2011-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL214822A0 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
| IL217912A (en) | History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It | |
| IL224288A (en) | Derivatives of converted pyrazolamide, pharmaceutical preparations containing them and their use | |
| IL214175A (en) | Derivatives of aminotetralin, their pharmaceutical compositions and their use | |
| IL199853A (en) | Converged history of 5-Hydroxy-Admentil-2-Reindeer and Pharmaceutical Preparation containing them | |
| AP2013006984A0 (en) | BicycloÄ3.2.1Üoctyl amide derivatives and uses of same | |
| IL233430A0 (en) | Polymyxin derivative, combined product, medical preparation and uses for it | |
| IL206594A (en) | The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations | |
| ZA201109034B (en) | Aminopyrrolidinone derivatives and uses thereof | |
| IL216113A (en) | Processed derivatives of indazole and azaza-indazole, pharmaceutical preparations containing them and their uses | |
| IL215497A0 (en) | Oxadiazile derivatives and pharmaceutical compositions containing them | |
| ZA201201727B (en) | Indenone derivative and pharmaceutical composition comprising same | |
| IL215835A (en) | Carboxamide compounds and their use as a drug | |
| IL210446A (en) | History of fibrin and medicinal preparations containing them | |
| PL2341047T3 (pl) | Pochodna cykloheksanowa i jej farmaceutyczne zastosowanie | |
| ZA201200079B (en) | Pharmaceutical compositions and solid forms | |
| IL215153A0 (en) | Amide derivative compounds, compositions comprising the same and uses there of | |
| IL220586A (en) | Carboxamide compound, a pharmaceutical composition containing it and its use | |
| IL216462A (en) | Pharmaceuticals containing nitrile history and uses | |
| EP2320738A4 (en) | SUBSTITUTED AMINOTHIAZOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF AND USE THEREOF | |
| GB0813340D0 (en) | Facilitating dynamic configuration of software products | |
| PT2484661T (pt) | Derivado de 2,3-di-hidro-1h-inden-2-il-ureia e sua aplicação farmacêutica | |
| IL211062A0 (en) | Pharmaceutical uses of lanosta-8,24-dien-3-ols | |
| IL207298A (en) | A derivative of benzenesulfonamide, pharmaceutical preparations containing it and its uses | |
| PT2597084T (pt) | Derivado de n-hidroxiformamida e medicamento contendo o mesmo |